Literature DB >> 21841100

Does family medicine have a professional obligation to play a leading role in pharmaceutical industry-sponsored drug research?: yes.

Anthony D D'Urzo1.   

Abstract

Mesh：

Year:  2011        PMID： 21841100      PMCID： PMC3155429     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  7 in total

1.  Tertiary research applied to primary care.

Authors:  Andrew J Cave
Journal:  Can Fam Physician       Date:  2002-11       Impact factor: 3.275

Review 2.  Pharmaceutical industry sponsorship and research outcome and quality: systematic review.

Authors:  Joel Lexchin; Lisa A Bero; Benjamin Djulbegovic; Otavio Clark
Journal:  BMJ       Date:  2003-05-31

3.  Physician professionalism and changes in physician-industry relationships from 2004 to 2009.

Authors:  Eric G Campbell; Sowmya R Rao; Catherine M DesRoches; Lisa I Iezzoni; Christine Vogeli; Dragana Bolcic-Jankovic; Paola D Miralles
Journal:  Arch Intern Med       Date:  2010-11-08

4.  Use and sources of medical knowledge.

Authors:  J Wyatt
Journal:  Lancet       Date:  1991-11-30       Impact factor: 79.321

5.  Health industry practices that create conflicts of interest: a policy proposal for academic medical centers.

Authors:  Troyen A Brennan; David J Rothman; Linda Blank; David Blumenthal; Susan C Chimonas; Jordan J Cohen; Janlori Goldman; Jerome P Kassirer; Harry Kimball; James Naughton; Neil Smelser
Journal:  JAMA       Date:  2006-01-25       Impact factor: 56.272

6.  Closing the door on pharma? A national survey of family medicine residencies regarding industry interactions.

Authors:  Adriane Fugh-Berman; Steven R Brown; Rachel Trippett; Alicia M Bell; Paige Clark; Anthony Fleg; Jay Siwek
Journal:  Acad Med       Date:  2011-05       Impact factor: 6.893

Review 7.  Barriers to participation in randomised controlled trials: a systematic review.

Authors:  S Ross; A Grant; C Counsell; W Gillespie; I Russell; R Prescott
Journal:  J Clin Epidemiol       Date:  1999-12       Impact factor: 6.437
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.